Merck BOVILIS® Vista® 5 VL5 SQ CFP Cattle Vaccine 20 mL/10 Dose
For vaccination of healthy cows, using five-way modified-live virus protection against Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea (BVD) Type 1 and Type 2, Parainfluenza3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV). Features five-way Leptospira protection including L. hardjo-bovis urinary shedding and Campylobacter fetus (Vibriosis).
**Ships Monday thru Thursday Only
See our Pharmaceutical Quality Program for more info.
This product is non-returnable.
Merck BOVILIS® Vista® 5 VL5 SQ CFP Cattle Vaccine 20 mL/10 Dose
Product Description
For vaccination of healthy cows, using five-way modified-live virus protection against Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea (BVD) Type 1 and Type 2, Parainfluenza3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV). Features five-way Leptospira protection including L. hardjo-bovis urinary shedding and Campylobacter fetus (Vibriosis).
Indications: This product is for the vaccination of healthy cows and heifers prior to breeding as an aid in the reduction of abortion due to infectious bovine rhinotracheitis (IBR); as an aid in the prevention of fetal infection, including persistently infected calves caused by bovine virus diarrhea virus (BVD) (Types 1 & 2). Reproductive Duration of Immunity (DOI) has been demonstrated to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). In addition, it can be used as an aid in the prevention of disease caused by IBR, BVD (Type 2); and bovine respiratory syncytial virus (BRSV), as an aid in the control of disease caused by BVD (Type 1), and parainfluenza3 virus (PI3), as an aid in reducing infertility (reproductive disease caused by Campylobacter fetus), and as an aid in preventing leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona) and as an aid in prevention of urinary shedding of hardjo organisms. Respiratory Duration of Immunity (DOI) has been demonstrated to be at least 182 days for IBR, at least 206 days for BVD (Type 1), and at least 200 days for BVD (Type 2). Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified live IBR and BVD containing vaccine(s) in this product line.
Mixing Directions: 10 Doses - Rehydrate freeze dried vial of Vista® 5 SQ with accompanying vial of VL5 SQ. Mix reconstituted vial well.
50 Doses - Rehydrate freeze dried vial of Vista® 5 SQ with part of the accompanying vial of VL5 SQ using the transfer needle provided (see pictorial directions). Mix reconstituted vial well and transfer rehydrated vaccine into VL5 SQ vial using transfer needle. Remove transfer needle from VL5 SQ vial and mix reconstituted vial well. Peel label from bottle of Vista® 5 SQ and place on VL5 SQ vial containing all vaccine.
Use Directions: Inject 2.0 mL subcutaneously 14-60 days prior to breeding. Annual revaccination is recommended. A revaccination dose can be administered at more frequent intervals based upon individual farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.
Item Number | MRK0135 |
---|---|
MPN | 006341 |
UPC | 662858904925 |
Weight | 5.000000 |
Brand | Merck |
Item Returns | This item can be returned |